Documents

A list of downloadable documents created during development.

Diabetes (type 2) - empagliflozin [ID641]: equality impact assessment - guidance review

Diabetes (type 2) empagliflozin: final scope

Diabetes (type 2) empagliflozin: final matrix

Diabetes (type 2) empagliflozin: NICE response to comments on the draft scope and provisional matrix

Diabetes (type 2) empagliflozin: Equality Impact Assessment

Diabetes (type 2) - empagliflozin: appendix B - draft scope for consultation (pre-referral) - May 2013

Diabetes (type 2) - empagliflozin: appendix C - provisional matrix (pre-referral) - May 2013